Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis EU Policy Lobbying Expenditures by Year
EU Policy Lobbying Expenditures (USD millions) ($M)
Novartis EU Policy Lobbying Expenditures: $3.08M in FY2025, up 35.7% from a year earlier.
Latest, FY2025
3.08
Period ended Dec 31, 2025
Change on a year earlier
+35.7%
2.27 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf
Where the FY2025 figure comes from
“| EU | 3 076 | 2 267 | 42”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | EU Policy Lobbying Expenditures (USD millions) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.08 | +35.7% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 2.27 | – | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
Cite this data
StockData. (2026). Novartis EU Policy Lobbying Expenditures ($M), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/gov-lobbying-eu-m
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.